NOS1 Antikörper (AA 19-31)
Kurzübersicht für NOS1 Antikörper (AA 19-31) (ABIN636185)
Target
Alle NOS1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 19-31
-
Aufreinigung
- Affinity chromatography purified
-
Immunogen
- nNOS antibody was raised in rabbit using AA 19-31 [PRKGPPLPNGDTEC] of NOS as the immunogen.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
WB: 1:500-1:1,000
Optimal conditions should be determined by the investigator. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- Lot specific
-
Buffer
- Affinity purified IgG supplied in PBS with 0.02 % NaN3.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium Azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 4 °C for short term storage. Aliquot and store at -20 °C for long term storage.
-
-
- NOS1 (Nitric Oxide Synthase 1, Neuronal (NOS1))
-
Andere Bezeichnung
- nNOS
-
Hintergrund
- Human nitric oxide synthases are a family of enzymes responsible for the synthesis of nitric oxide from L-arginine and molecular oxygen. There are at least three nitric oxide synthases, NOS I, also known as neuronal NOS or nNOS, NOS II, which is referred to as inducible NOS or iNOS and NOS III, also known as endothelial NOS or eNOS. nNOS plays a role in the upregulation of microglial phospho-p38 MAPK. Such p38 MAPK activation in microglia is consistent with a potential role in the development of morphine antinociceptive tolerance.
-
Pathways
- Negative Regulation of Hormone Secretion, Myometrial Relaxation and Contraction
Target
-